EX-5.1 2 tm2417421d6_ex5-1.htm EXHIBIT 5.1

 

Exhibit 5.1

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on Form F-10 of our report dated April 1, 2024, relating to the consolidated financial statements of Cardiol Therapeutics Inc. (the “Company”), appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023.

 

We also consent to the reference to us under the caption “Experts” in the Registration Statement.

 

/s/ BDO Canada LLP  
   
Chartered Professional Accountants, Licensed Public Accountants   
Oakville, Canada   
July 12, 2024